Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6649659 | GLAXOSMITHKLINE LLC | Atovaquone pharmaceutical compositions |
Jul, 2016
(7 years ago) | |
US6649659 (Pediatric) | GLAXOSMITHKLINE LLC | Atovaquone pharmaceutical compositions |
Jan, 2017
(7 years ago) |
Market Authorisation Date: 08 February, 1995
Treatment: Treatment of pneumocystis carinii infections
Dosage: SUSPENSION;ORAL